Delivery Order SPE2DB22D3102-SPE2DB25FL2FG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,920.27 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on July 24, 2025, with completion scheduled for July 25, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a single delivery of the pediatric vaccine product to support federal medical supply requirements. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency awarded a $5,151.24 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Pediarix 0.5 ML syringes. This non-set-aside, firm fixed price contract is classified as a delivery order and has an ultimate completion date of July 24, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,344.50 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ML syringes. This firm fixed price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a pediatric vaccine delivery under the agency's medical supply chain operations. The award utilizes no set-aside designation and was competitively awarded through open competition. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,166.15 firm fixed price delivery order for Pediarix 0.5 mL syringes, with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,253.00 to supply Pediarix 0.5 ML syringes. This contract, which is not set-aside, was competitively awarded with a firm fixed price structure and an ultimate completion date of July 21, 2025. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency valued at $3,261.55 for Pediarix 0.5 ML syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a $10,577.34 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Pediarix 0.5 mL syringes. This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. Performance will take place at AmerisourceBergen's corporate...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,658.40 firm fixed-price contract is for the supply of Pediarix 0.5 ML syringes, a pediatric vaccine. The contract has an ultimate completion date of August 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded various federal contracts to provide a wide range of medical products, including specialty medications, drugs, vaccines,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 mL syringes, valued at $2,797.02 under firm fixed pricing. This non-competitive delivery order, issued on July 31, 2025, with completion scheduled for August 1, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract utilizes AmerisourceBergen's existing indefinite delivery contract vehicle with the DLA, enabling rapid fulfillment...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pediarix HIB vaccine in 0.5 milliliter vials, with a ceiling value of $1,326.85 and an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under the company's larger...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2FGDelivery Order
The Defense Logistics Agency awarded a $1,299.69 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Pediarix 0.5 ML syringes. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The vaccine product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025, reflecting the expedited nature of pharmaceutical supply chain fulfillment for federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for military and federal medical procurement. The company maintains extensive federal contracting relationships focused on delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies the company's role in supporting routine medical supply needs within the broader federal pharmaceutical logistics framework managed by the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/24/25 |